Skip to main content

Table 2 Take rates in glioblastoma group and survival time of tumor-bearing mice.

From: Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar

Generation

No. of mice

No. of tumor-bearing mice1

Take rate(%)

survival time(d)

1

10

9

90

32.4 ± 2.1

2

10

9

90

30.4 ± 2.2

3

10

10

100

29.9 ± 2.1

4

10

10

100

28.4 ± 2.7

5

10

10

100

23.9 ± 1.7

6

10

10

100

23.0 ± 0.9

7

10

10

100

22.8 ± 1.3

8

10

10

100

21.7 ± 1.3

9

10

10

100

23.2 ± 0.6

10

10

10

100

22.0 ± 1.8

11

10

10

100

21.3 ± 1.2

12

10

10

100

21.4 ± 1.8

13

10

10

100

22.4 ± 0.9

  1. 1Each mouse was implanted with one graft(Site: right caudate nucleus of nude mice)
  2. Take rates in glioblastoma group and survival time of tumor-bearing mice in the intracranial xenotransplantation